ESR1 and triple-negative breast carcinoma: Triple-negative breast cancer (TNBC) accounts for 15-20% of breast cancer cases and lacks expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) [3].